Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis
Kyle L. Poulsen, Xiude Fan, Christopher D. Kibler, Emily Huang, Xiaoqin Wu, Megan R. McMullen, Lin Leng, Richard Bucala, Meritxell Ventura-Cots, Josepmaria Argemi, Ramon Bataller, Laura E. Nagy
Kyle L. Poulsen, Xiude Fan, Christopher D. Kibler, Emily Huang, Xiaoqin Wu, Megan R. McMullen, Lin Leng, Richard Bucala, Meritxell Ventura-Cots, Josepmaria Argemi, Ramon Bataller, Laura E. Nagy
View: Text | PDF
Research Article Hepatology Inflammation

Role of MIF in coordinated expression of hepatic chemokines in patients with alcohol-associated hepatitis

  • Text
  • PDF
Abstract

The chemokine system of ligands and receptors is implicated in the progression of alcohol-associated hepatitis (AH). Finding upstream regulators could lead to novel therapies. This study involved coordinated expression of chemokines in livers of healthy controls (HC) and patients with AH in 2 distinct cohorts of patients with various chronic liver diseases. Studies in cultured hepatocytes and in tissue-specific KO were used for mechanistic insight into a potential upstream regulator of chemokine expression in AH. Selected C-X-C chemokine members of the IL-8 chemokine family and C-C chemokine CCL20 were highly associated with AH compared with HC but not in patients with liver diseases of other etiologies (nonalcoholic fatty liver disease [NAFLD] and hepatitis C virus [HCV]). Our previous studies implicate macrophage migration inhibitory factor (MIF) as a pleiotropic cytokine/chemokine with the potential to coordinately regulate chemokine expression in AH. LPS-stimulated expression of multiple chemokines in cultured hepatocytes was dependent on MIF. Gao-binge ethanol feeding to mice induced a similar coordinated chemokine expression in livers of WT mice; this was prevented in hepatocyte-specific Mif–KO (MifΔHep) mice. This study demonstrates that patients with AH exhibit a specific, coordinately expressed chemokine signature and that hepatocyte-derived MIF might drive this inflammatory response.

Authors

Kyle L. Poulsen, Xiude Fan, Christopher D. Kibler, Emily Huang, Xiaoqin Wu, Megan R. McMullen, Lin Leng, Richard Bucala, Meritxell Ventura-Cots, Josepmaria Argemi, Ramon Bataller, Laura E. Nagy

×

Figure 4

MIF is required for LPS-mediated upregulation of chemokine mRNA expression in response to LPS challenge.

Options: View larger image (or click on image) Download as PowerPoint
MIF is required for LPS-mediated upregulation of chemokine mRNA expressi...
(A) AML-12 cells were treated with LPS at the indicated concentrations for 90 minutes, and expression of Cxcl1, Lix, Ccl2, and Ccl20 mRNA was determined by qPCR. (B) AML-12 cells were pretreated with VEH (0.1% DMSO) or MIF098 (50 μM) prior to LPS challenge for 90 minutes. Expression of Cxcl1, Lix, Ccl2, and Ccl20 mRNA was determined and normalized to Basal/VEH or LPS/VEH as indicated. (C) AML-12 cells were treated with 1 ng/mL LPS for 30 minutes, and phosphorylation of ERK and p65, as well as the abundance of IκBα, was determined by Western blot. GAPDH was used as a loading control. Values are expressed as means ± SEM. *P < 0.05 versus. BAS controls (n = 4-7). Means with different letters are significantly different, P < 0.05, by 2-way ANOVA with least square means multiple comparison tests. See complete unedited blots in the supplemental material.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts